Boult Wade Tennant
/bulletin

Archives: Bulletins

July 25, 2020

Emson v. Hozelock: Public prior use and a “mere paper proposal”

On 8 July 2020, the Court of Appeal issued its decision in the Emson v. Hozelock case ([2020] EWCA Civ 871). The

July 19, 2020

Patentability of simulations – Decision of the Enlarged Board of Appeal for G1/19.

The thorny issue of the patentability (or otherwise) of inventions involving computer simulations at the EPO has been provided with an ending,

July 14, 2020

The CJEU Confirms that Copyright Can Cover Products Designed to Achieve a Technical Result

When does a technical product become eligible for copyright protection? This is the question the Court of Justice of the European Union

July 3, 2020

Criteria for basing SPCs on functional claims clarified by CJEU in Royalty Pharma

In the latest of a series of judgments concerning the interpretation of Article 3(a) of the SPC Regulation, the Court of Justice

June 17, 2020

Reaffirmation of the Allowability of Technical Implementations of Business Methods at the EPO

On 3 April 2020, the Technical Board of Appeal of the European Patent Office issued a decision for Appeal T1749/14 against refusal

June 10, 2020

Special reasons? Remittals from the EPO Boards of Appeal

One of the changes to the Rules of Procedure of the Boards of Appeal (RPBA) which came into force on 1 January

June 4, 2020

The EPO rules that plants and animals exclusively obtained by essentially biological processes are not patentable

The Enlarged Board of Appeal (EBA) of the EPO has confirmed in decision G3/19 that plants, plant material or animals exclusively obtained

March 24, 2020

Changes to unregistered designs right after Brexit

Many designers rely on Unregistered Design Rights to protect their products in the UK and the EU. However, designers need to be

March 18, 2020

Continued growth for UK filings at the EPO

The European Patent Office (EPO) has published its latest statistics for European patent applications in 2019. In addition to overall surges in

March 17, 2020

Reconsideration Of Claims Previously Held Invalid Barred

In the latest instalment of a prolonged and litigious saga between Eli Lilly and Genentech, the UK High Court has ruled that,